In the studies reported here we have examined the role of the medial prefrontal cortex (MpFC) in regulating hypothalamic-pituitary-adrenal (HPA) activity under basal and stressful conditions. In preliminary studies we characterized corticosteroid receptor binding in the rat MpFC. The results revealed high-affinity (K,, -1 nM) binding with a moderate capacity (42.9 +-3 fmol/mg) for 3H-aldosterone (with a 50-fold excess of cold RU28382; mineralocorticoid receptor) and high-affinity (& -0.5-1.0 nM) binding with higher capacity (183.2 f 22 fmol/mg) for 3H-RU 28362 (glucocorticoid receptor).
Lesions of the MpFC (cingulate gyrus) significantly increased plasma levels of both adrenocorticotropin (ACTH) and corticosterone (CORT) in response to a 20 min restraint stress. The same lesions had no effect on hormone levels following a 2.5 min exposure to ether. Implants of crystalline CORT into the same region of the MpFC produced a significant decrease in plasma levels of both ACTH and CORT with restraint stress, but again, there was no effect with ether stress. Neither MpFC lesions nor CORT implants had any consistent effect on A. The hypothalamic-pituitary-adrenal (HPA) response to stress comprises a major element of the organism's reaction to stimuli that threaten homeostasis (i.e., stress). The characterization of corticotropin-releasing hormone (CRH) by Vale's group in 198 1 (e.g., Rivier et al., 1982) provided the basis for a wealth of studies on the transduction of neural signals into the activation of the pituitary-adrenal system. These studies have demonstrated that the activation of pituitary adrenocorticotropin (ACTH) release is mediated by the secretion of CRH, and often cosecretagogues such as arginine vasopressin (AVP) and oxytocin, from neurons with axon terminals in the median eminence of the hypophysial portal system (see Antoni, 1986; Gibbs, 1986; Rivier and Plotsky, 1986; Plotsky, 1987) . For the most part, these axons arise from peptidergic neurons in the paraventricular nucleus of the hypothalamus (PVN; Swanson et al., 1987) .
In addition, there is now a much better understanding of the processes by which the adrenal glucocorticoids feed back onto pituitary and brain sites to inhibit stress-induced HPA activity (i.e., glucocorticoid negative-feedback). The results from a series of studies from Dallman's laboratory, including studies on the diurnal variation in glucocorticoid control of stress-induced ACTH release, have suggested that the primary sites mediating glucocorticoid negative-feedback inhibition are distal to the CRH/AVP neurons of the PVN (see Dallman et al., in press ). Thus, perhaps one of the most interesting features to emerge from the more recent studies on this topic is the importance of extrahypothalamic sites as targets for the negative-feedback actions of circulating glucocorticoids. Most notable among these regions is the hippocampus (see Sapolsky et al., 1984 Sapolsky et al., , 1986 McEwen et al., 1986; Herman et al., 1989; Jacobson and Sapolsky, 199 1) . In the rat, this structure contains both mineralocorticoid and glucocorticoid receptors that bind with high affinity to corticosterone (CORT; see Reul and De Kloet, 1985; McEwen et al., 1986; Funder and Sheppard, 1987) . Studies using antagonists of the two receptor sites have implicated both receptors in the negative-feedback actions of CORT (Ratka et al., 1989; Bradbury et al., 199 1) .
In addition to the hippocampus, there is evidence for a high density of corticosteroid receptors in the cerebral cortex of both the rat (see Meaney and Aitken, 1985; McEwen et al., 1986) and human (Sarrieau et al., 1988) . Indeed, the original autoradiographic studies from the McEwen lab (see McEwen et al., 1986 , for a review) indicated a high retention of 3H-CORT in the cortex, particularly in the medial regions of the frontal cortex. Feldman and Conforti (1985) found that electrical stimulation of the frontal cortex altered plasma levels of CORT in the rat. Herman et al. (1989) recently reported that cortical lesions result in increased CRH and AVP mRNA levels in the PVN. Moreover, certain states associated with increased glucocorticoid production, such as anxiety and depression, are known to be associated with frontal cortex dysfunction (see Gray, 1982) . Finally, although rather little is known about the neuroendocrine role of the frontal cortex, the importance of this structure in behavioral, emotional, and autonomic responses to stress has been well established (for reviews, see Gray, 1982; LeDoux, 1987) .
In the studies reported here we examined the role of the medial prefrontal cortex (MpFC) in the regulation of HPA function under both resting and stressful conditions. The results suggest that the MpFC can influence the HPA response to stress and that this effect depends upon the nature of the stress.
Materials and Methods
Animals. Male Long-Evans hooded rats obtained from Charles River Canada (St. Constant, QuCbec) and weighing approximately 350 gm were used in these studies. The animals were housed at the Research Center for at least 1 month prior to testing. The animals were provided with food and water ad libitum, and housed in an animal facility maintained on a 12 hr: 12 hr light/dark cycle (lights off at 2000 hr). All animals were 4-5 months of age at the time of testing.
Four days prior to testing animals were implanted with indwelling jugular catheters under Metophane anesthesia. Catheterized animals were single housed for the remainder of the study. Bilateral adrenalectomies were performed under Metophane anesthesia and adrenalectomized animals were maintained on 0.9% saline as drinking water. All procedures were conducted in accordance with the guidelines of the Canadian Council on Animal Care and the McGill University Animal Care Committee.
Lesion studies. Bilateral thermal lesions ofthe medial prefrontal cortex (medial prefrontal cortex/cingulate gyrus) were made under pentobarbital (Nembutal) anesthesia with the electrode tip of a radiofrequency lesion generator (Radionics Inc., Burlington, MA) maintained at 55°C for 1 min. The following stereotaxic coordinates (Paxinos and Watson, 1982) were used with bregma as the anterior-posterior reference to the dura: AP +3.0 mm, ventral -4.0 mm, and 0.8 mm from the midline. Sham-operated animals received the same treatment as the lesioned animals, but the electrode tip was simply lowered. Animals were tested 2 weeks following lesions. Following testing the animals were perfused under deep anesthesia, the brains were removed and sectioned, and the relevant sections were Nissl stained for verification of the location and estimation of the minimal/maximal extent of the lesion. Steroid implants. Cannulas (24 gauge) containing pure crystalline CORT (Sigma, St. Louis, MO) were implanted bilaterally into the MpFC under pentobarbital anesthesia using the same stereotaxic coordinates as described for the lesion studies. Cannulas, containing 150 fig of CORT, were tightly secured to the skull with dental acrylic. Control animals received the same surgical procedure and were implanted with cannulas containing cholesterol. Testing was performed 4 d following surgery.
Following testing, the cannulas were removed and weighed, and in each case approximately 80% of the CORT remained in the cannula. Brains were processed as described above in order to verify the placement of the cannula. In order to determine the diffusion of the steroid away from the cannula tip, a separate group of animals were implanted unilaterally with cannula containing 'H-CORT plus cold CORT using a procedure previously described by Meaney and McEwen (1986) . The radiolabeled steroid was put into solution in ethanol with cold CORT, dried under nitrogen, and tapped into the cannula (-150 pg CORT per cannula) using the same procedure as described above. Four days following surgery the animals were killed and the degree of steroid diffusion was assessed in microdissected tissue samples. Briefly, animals were decapitated under anesthesia and brains frozen on dry ice. The brains were sectioned (300 pm thickness) and l-mm-diameter areas (i.e., punches) in the vicinity of the cannula tip were removed using the atlas of Palkovits and Brownstein (1988) . Steroid was extracted from dispersed tissue samples with 200 ~1 of ethanol at 37°C. Following extraction, the samples were centrifuged at 20,000 x g and 100 ~1 aliquots of the supematant/extract were then counted in 5 ml of scintillation cocktail (Liquiscent, National Diagnostics, Sommervile, NJ) using an LKB scintillation counter at 40% efficiency. The remaining pellet was resuspended in 0.1 N NaOH and protein concentrations were determined using the method of Bradford (1976) . The results were expressed as cpm/mg protein.
Blood samolina under basal and stressful conditions. Basal CORT levels over the diurnal cycle were mea&red as previously described (e.g., Meaney et al., 1989) . Briefly, blood samples (-50 ~1) were taken from the tail vein at six time points over a 24 hr cycle. Samples were taken in heparinized tubes, placed on ice, centrifuged, and stored at -30°C until assayed. Blood samples (250 ~1) for ACTH determination were taken at a separate time, 2 hr following the time of lights on (1000 hr, light phase) and off (2200 hr, dark phase) in tubes containing EDTA and trasylol, centrifuged, stored at -8O"c, and assayed for plasma ACTH within 1 week of the experiment (note that because of the larger sample required, sampling for ACTH levels occurred only at two time points). In all cases, animals were sampled less than 20 set following their removal from their home cages in order to obtain valid estimates of basal hormone levels.
Restraint stress was performed between 1300 and 1500 hr using tubular, plastic restrainers lined with foam rubber. The animals were placed into the restrainers for a 20 min period. A blood sample (-150 ~1) was taken immediately before the animal was placed into the restrainer, and this sample was used as an estimate of basal hormone levels prior to stress. Blood samples (-150 ~1) were then taken from the same animals via a jugular catheter at various times during and following the termination of the stressor. The time 0 point was taken just before releasing the animals from the restrainers (i.e., 0 min following termination of the stressor) and represents the peak stress value (see Meaney et al., 1989) . For ether stress, animals were maintained for 2.5 min in a glass container lined with absorbent paper soaked with ether. Samples were collected via a jugular catheter immediately following ether exposure and at various times thereafter. Blood samples were processed as described above.
Radioimmunoassays. Plasma CORT was measured using the radioimmunoassay of Krey et al. (1975) with a highly specific CORT antiserum (B3-163, Endocrine Sciences, Tarzana, CA) and jH-CORT (10 1 .O pCi/mmol; New England Nuclear, Boston, MA) as tracer. The minimum level of detection with the assay is 1 rig/ml. The antiserum cross-reacts slightly with desoxycorticosterone (-4%) but not with cortisol (< 1%). The intra-and interassay coefficients of variation are 8.9% and 11.2%, respectively. Plasma ACTH was measured using the radioimmunoassay kit of ICN Biomedicals (Carson, CA) with jZ51-ACTH as tracer. The ACTH antibody cross-reacts 100% with ACTH,.,, and ACTH,.,,, but less than 1% with P-endorphin, CX-and P-melanocyte-stimulating hormone (MSH), and LY-and P-lipotropin. The intra-and interassay coefficients of variation are 6.0% and 10.7%, respectively. The minimal detectable level of plasma ACTH is about 10 pg/ml.
Corticosteroid receptor binding assays. Animals were killed by decapitation 12-14 hr following adrenalectomy, a time period that allows for the clearance of the endogenous steroid. Following decapitation the brain was quickly removed and placed on ice, and the prefrontal cortex, hippocampus, hypothalamus, amygdala, and/or pituitary were dissected, frozen on dry ice, and stored at -80°C until assayed. The tissue was homogenized in 30 mM Tris, 1 mM EDTA, 10 mM sodium molybdate, 10% v/v glycerol, and 1 mM dithiothreitol (TEDGM; pH adjusted to 7.4). The homogenate was centrifuged at 2°C for 60 min at 105,000 x g in a Beckman L8-80 ultracentrifuge. For determination of glucocorticoid receptor binding capacity, aliquots (150 ~1) of the soluble fraction were incubated with 100 ~1 aliquots of TEDGM containing )H-RU 28362 (77.9 Ci/mmol; New England Nuclear, Boston, MA) in a concentration range of 0.1-10 nM at 0-4"C for 20-22 hr (a time that has been shown to be sufficient for maximal exchange to occur and during which binding is stable: see Kalimi and Hubbard. 1983: Reul and De Kloet, 1985; Reul et al.,'1 987a,b) . We routinely useexchahge conditions in binding experiments in order to minimize the effects of any residual steroid in the tissue. Nonspecific binding was determined in parallel incubations containing a 500-fold excess of unlabeled CORT. RU 28362 has been shown to bind selectively to the glucocorticoid receptor, showing very little affinity for the mineralocorticoid receptor (Philibert and Moguilewsky, 1983; Coirini et al., 1985) . For single point assays aliquots of the soluble fraction were incubated with a saturating 8 nM concentration of 'H-RU 28362.
Mineralocorticoid receptor binding capacity in the MpFC and the hippocampus was measured using 'H-aldosterone with a 50-fold excess of cold RU28362 in order to preclude radioligand binding to glucocorticoid receptor sites. Aliquots (150 ~1) of soluble fractions prepared from hippocampal tissue were incubated at O+C for 20-22 hr in the presence of a concentration range of )H-aldosterone (82.0 &Ymmol; New England Nuclear, Boston, MA) of 0.3-15 nM in TEDGM. Nonspecific binding was determined in parallel incubations containing a 500-fold excess of unlabeled CORT.
Sephadex LH-20 columns (4 x 1 cm), made from disposable pipette tips and equilibrated with TEDGM, were used to separate bound from Figure 1 . Shown are photomicrographs of representative lesions (top) and cannulas placements (middle), along with a schematic guide to the relevant sections. The maximal extent of the lesion is depict in the above section and characterizes the damage that includes primarily the cingulate cortex (area 3; Cg) and the infralimbic cortex (Kc). The dorsal portion of the dorsal peduncular cortex was also damaged, although in no cases was this nuclei entirely damaged. The damage extended anteriorly into the cingulate cortex, without involving any other regions. At the more posterior extent, the lesion involved the indusium griseum and the cingulate cortex (area 2). Animals showing damage involving other structures or with damage that was not bilateral were excluded from the study. The cannula placement centered on the ventral portion of the cingulate gyrus (area 3) and the dorsal portion of the infralimbic cortex. The 1 mm region above the cannula tip was the only region outside of the target area of the cannula tip to show levels of 'H-CORT that were significantly higher than background (see Results and Fig. 2 ). This area included only the dorsal portion of the cingulate gyrus. Data from animals that do not show bilateral implants in the same region were excluded. Analysis was based on the atlas of Paxinos and Watson (1982) . unbound steroid. Following the incubation, 100 ~1 of the incubates were washed into the columns with 100 ~1 of TEDGM. The columns were eluted 30 min later with 500 pl of TEDGM into minivials, which were then filled with 5 ml of Liquiscent (National Diagnostics, Somerville, NJ), and counted in a Packard scintillation counter at 40% efficiency. Protein content was determined using the method of Bradford (1976) and the results were expressed as femtomoles (fmol)/mg protein specific binding. Protein concentrations ranged from 300 to 500 &ml for the brain tissue assays and from 200 to 300 &ml for the pituitary assays. Sfatisticul analysis. Statistical analysis of data from multiple groups was performed using analysis of variance with Tukey post hoc tests where appropriate. Comparisons involving two means were performed using unpaired t tests. The results of the saturation experiments were analyzed using Scatchard plot analysis (Scatchard, 1949) in order to derive affinity constants (&) and estimates of binding capacity (B,,,).
Results
Histology.
The maximal extent of the damage associated with the radiofrequency lesions was assessed in Nissl-stained sections and is summarized in Figure 1 . The lesions were centered on the cingulate gyrus region of the MpFC, with some damage extending into the infralimbic region.
The results of the steroid diffusion study are presented schematically in Figures 1 and 2 . Steroid extract from plasma showed that radioactivity levels were not significantly different from background. Likewise, we found no evidence for radiolabeled CORT in pituitary extracts. The distribution of the radioactivity in the brain was largely confined to a 1 mm region surrounding the target site of the cannula tip (see Fig. 2 ). Outside of this region, radioactivity levels generally did not significantly exceed background. The only exception was in the 1 mm punch directly above the location of the cannula tip. However, while 3H-CORT levels in this region did exceed background, they were < 15% of those found in the 1 mm region of the cannula tip. In a preliminary study, we found the same distribution of radiolabeled CORT in animals killed 36 hr following surgery. These findings indicate that throughout the 96 hr period between CORT implant and stress testing, the steroid remained confined to the area of the implant. The amount of CORT within the l-mmdiameter punch at the level of the cannula tip was estimated on the basis on the known specific activity of the radiolabeled steroid and averaged 16 + 4 ng. cortex, with a moderate capacity (II,,,,, = 42.9 ? 3 fmol/mg protein; n = 5). Likewise, there was high-affinity RU 28362 binding (Kd = 0.8 f 0.1 nM), with about four-to fivefold greater density of the glucocorticoid receptor sites (B,,, = 183.2 f 22 fmol/mg protein; n = 5). Prefrontal cortex lesions did not alter SH-RU 28362 binding in the pituitary, hippocampus, hypothalamus, amygdala, or pituitary, or 3H-aldosterone binding in the hippocampus (data not shown). These findings suggest that there was no effect of the lesions on the sensitivity of these structures to circulating CORT. Stress-induced HPA activity. Restraint stress produced a rapid and significant (P < 0.00 1) increase in plasma ACTH and CORT levels (see Fig. 5 ). Peak levels of ACTH and CORT during restraint did not differ between lesion and control animals. However, plasma ACTH levels were significantly (P < 0.05) higher in the lesioned animals at 20 and 40 min following the termination of restraint. Likewise, plasma CORT levels were significantly (P < 0.05) higher in the lesioned animals 30, 60, and 120 min following restraint. Lesions of the MpFC had no effect on the clearance rate for CORT (see Fig. 7 ). These findings suggest that differences in plasma CORT levels reflect differences in hormone secretion rates and not in clearance from the plasma compartment.
Ether exposure provoked five-to eightfold increases in plasma ACTH and CORT (see Fig. 6 ). Elevations in both hormones were substantially higher following ether than those observed with restraint. However, at no time point did lesion and control animals differ significantly in plasma levels of either ACTH or CORT.
CORT implants into the MpFC resulted in significantly (P < 0.01) decreased levels of plasma ACTH in response to restraint stress (see Fig. 8, top) . Peak CORT levels during restraint stress were also significantly reduced in the CORT-implant animals (23.2 f 4 vs 36.3 f 3 pg/dl, P < 0.05). However, plasma ACTH responses to ether exposure were not significantly altered in CORT-implant animals compared with cholesterol-implanted controls (Fig. 9, top) .
Discussion
The medial region of the rat prefrontal cortex contains both mineralocorticoid and glucocorticoid receptors for CORT (see time points following a 2.5 min period of ether stress. Fig. 3 ). These receptor sites share the binding properties (i.e., affinities for aldosterone and RU 28362) of mineralocorticoid and glucocorticoid receptors described elsewhere in the rat brain (see Reul and De Kloet, 1985; McEwen et al., 1986; Funder and Sheppard, 1987) . The findings from these receptor binding assays are consistent with previous reports of 3H-CORT uptake in the rat cerebral cortex and the idea that the cortex is a corticosteroid target site (see McEwen et al., 1986) .
within the MpFC resulted in a decreased HPA response to restraint.
Lesions of the cingulate gyrus region of the MpFC were associated with significantly increased plasma levels of both ACTH and CORT following restraint stress. CORT implants into this same region of the MpFC significantly reduced plasma ACTH and CORT responses to restraint stress. These findings are consistent with the idea that the prefrontal cortex mediates an inhibitory effect of glucocorticoids on stress-induced HPA activity. Thus, the absence of a prefrontal cortex substrate resulted in an exaggerated HPA response to restraint, while an experimental condition that mimics elevated CORT levels locally It is interesting to note that the lesion effect was observed only in the poststress period; there was no lesion effect on the peak levels of either ACTH or CORT. In contrast, there was a robust effect of CORT implants on the peak ACTH levels in response to restraint stress. This distinction suggests that the inhibitory influence of the prefrontal cortex is exerted only in the presence of elevated glucocorticoid levels. Thus, the lesion effect was apparent only once the increase in CORT levels had occurred (i.e., the stress period). However, it is also important to note that these experiments were conducted during the mid-A.M. phase of the cycle, when plasma CORT levels are lowest. It is very likely that the elevated basal CORT levels observed in the PM phase of the cycle would be sufficient to reveal an effect of prefrontal cortex lesions on peak HPA responses to restraint stress.
These findings also suggest that the effects observed here likely involve the glucocorticoid receptor population in the prefrontal cortex. The affinity of the mineralocorticoid receptor for CORT is about 5-1 O-fold higher than that of the glucocorticoid receptor (-0.5-1.0 vs 2.0-10.0 nM; see ReulandDe Kloet, 1985; McEwen et al., 1986; Funder and Sheppard, 1987) . Under resting conditions in the A.M., circulating CORT levels are sufficient to occupy the majority of mineralocorticoid, but not glucocorticoid, receptor sites. As CORT levels rise, either in response to the circadian peak or to stress, there is an increase in glucocorticoid receptor occupancy, with little change in mineralocorticoid receptor occupancy (see De Kloet, 1985, 1987a,b; Meaney et al., 1988a) . Akana et al. (1986, in press ) have provided evidence for the idea that glucocorticoid negative-feedback in response to basal A.M. CORT levels is mediated via the mineralocorticoid receptor (see also Dallman et al., 1989) . The fact that prefrontal cortex lesions did not affect the peak HPA response to restraint stress in the A.M. phase of the cycle is consistent with the idea that the glucocorticoid action at this site requires higher CORT levels, which would imply a primary role for the glucocorticoid receptor. Note, the CORT implants into the MpFC, which mimic conditions of elevated CORT levels observed during stress or during the P.M. phase in CORT, did reduce the peak ACTH response to restraint. This reasoning is also consistent with the finding that the density of glucocorticoid receptor sites in the prefrontal cortex was about four to five times higher than that for mineralocorticoid sites. By contrast, in the dorsal hippocampus, where both mineralocorticoid and glucocorticoid receptor sites are thought to mediate corticosteroid negative-feedback effects, there are comparable levels of the two receptors (e.g., Reul and De Kloet, 1985) . stressors, but is overridden by the intense excitatory drive associated with more severe forms of stress. The HPA axis appears to respond in proportion to the intensity of the stressor (see Dallman et al., 1987) and plasma levels of both ACTH and CORT were appreciably higher following ether exposure than followingrestraint (see also Nakane et al., 1985) . Hence, it seems reasonable (and intuitively appealing) to consider ether as the more severe stressor. If this is the case, then the differential effects of the MpFC manipulations may not necessarily reflect differences in the activity of this region under various forms of stress. Clearly, studies using a wider variety of stressors are required before we can resolve this question, In contrast to the effects under restraint stress, neither the Alternatively, it is possible that the relevant frontal cortex MpFC lesions nor CORT implants altered plasma ACTH or projections impinge upon the hypothalamic-hypophysial signal CORT responses to ether stress. The stress-dependent nature involved in mediating ACTH release following restraint, but of the prefrontal cortex influence over HPA activity is a very not ether. However, the results of several studies have failed to interesting and novel finding. It is possible that the increased draw any clear distinction between the ACTH secretagogues negative-feedback signal associated with CORT implants into involved in restraint and ether stress. Immunoneutralization of the MpFC is sufficient to dampen the HPA response to mild either CRH or AVP attenuates the increase in plasma ACTH associated with restraint or ether. It appears that the increased release of pituitary ACTH that occurs in response to both forms of stress involves CRH and AVP (Linton et al., 1985; Nakane et al., 1985) . Thus, the specificity of the prefrontal cortex manipulations is probably not associated with effects on selected ACTH secretagogues. A third possible explanation for the differential effects of prefrontal cortex manipulations on restraint versus ether stress concerns the nature of the relevant projections from the MpFC. It is possible that projections from the prefrontal cortex involve sites that mediate HPA responses to restraint, but not to ether. However, this is difficult to evaluate in the absence of a clear understanding of the CNS pathways that mediate the effects of these stimuli on the HPA axis. Nevertheless, there are known projections from the prefrontal cortex that are certainly could regulate HPA function and that may underlie the effects observed with restraint stress. Thus, an elevated CORT signal at the level of the MpFC could attenuate an HPA response to stress via inputs from this region to the PVN, presumably onto CRH/ AVP neurons, or to extrahypothalamic nuclei that comprise the excitatory neural drive over HPA function. There is anatomical evidence to support both possibilities. While the prefrontal cortex does not seem to project directly to the PVN, this region is a major source of afferents to the septum (see Swanson and Cowan, 1976) which in turn projects to the PVN (Sawchenko and Swanson, 1983) . In addition, the prefrontal cortex also projects to regions such as the nucleus of the solitary tract (van der Kooy et al., 1984) which is a major source of catecholaminergic input into the PVN. Considering the central role of ascending catecholaminergic systems in activating the release of ACTH secretagogues from the PVN (e.g., Plotsky, 1987a,b) , this projection might also be a source of regulation over HPA activity. In addition to the septum, there are other limbic projection sites from the prefrontal cortex, such as the amygdala (Saper, 1982) that are involved in autonomic function. Interestingly, lesions of the central nucleus of the amygdala alter HPA responses to restraint stress (Beaulieu et al., 1986 (Beaulieu et al., , 1987 .
Alternatively, the relevant projections from the prefrontal cortex might involve hypothalamic sites. In support of this idea, Feldman and Conforti (1985) reported that the effects of electrical stimulation of the frontal cortex on plasma CORT levels was blocked by lesions of the medial forebrain bundle (MFB). The frontal cortex has been shown to send projections directly into the MFB at the level of the lateral hypothalamus (Yamamoto and Shibata, 1975; Beckstead, 1979; Kita and Oomura, 198 1) . The MFB fibers course through the lateral hypothalamus and project into the PVN (see Sawchenko and Swanson, 1983) . The MFB contains ascending catecholaminergic fibers that are known to be involved in the stimulation of the HPA axis. Thus, Feldman and Conforti (1985) proposed that the relevant cortical input was at the level of the lateral hypothalamus and involved projections to the MFB. There are certainly numerous, potentially relevant projections from the prefrontal cortex, and there is no reason to consider these possibilities as mutually exclusive.
In a series of developmental studies we have shown that postnatal handling increases glucocorticoid receptor density (see Meaney et al., 199 1, for a review) and glucocorticoid receptor mRNA levels (Larocque et al., 1992) in selected brain regions, notably the dorsal hippocampus and the frontal cortex. As adults, handled animals show reduced plasma ACTH and CORT responses to a wide variety of stressors (Levine, 1957 (Levine, , 1962 Meaney et al., 1988b Meaney et al., , 1989 and reduced CRH and AVP content in Time (min) Figure 9 . Mean ? SEM plasma ACTH and CORT levels in animals with CORT or cholesterol (control) implants into the MpFC (n = 8 per group) prior to (PRE), during (0 min), and following a 2.5 min period of ether stress. *, P < 0.05.
the median eminence and hypothalamic CRH mRNA levels (Viau et al., 1993 ; M. J. Meaney and P. M. Plotsky, unpublished observations). While the handling effect is known to involve changes at the level of the hippocampus, the present data suggest that changes in glucocorticoid receptor density in the frontal cortex might also be of importance for the effect of handling on HPA function. Thus, handling increases glucocorticoid receptor density in the frontal cortex, which could then result in increased sensitivity to elevated CORT and in enhanced inhibition of plasma ACTH and CORT responses to stress. The role of the prefrontal cortex in the regulation of HPA function is of considerable interest and provides a mechanism whereby cortical activity might regulate rudimentary endocrine responses to conditions that threaten homeostasis. There is now considerable evidence for the importance of the hippocampus in the regulation of HPA function and, in particular, as a critical target site for the negative-feedback effects of glucocorticoids. Interestingly, the hippocampus and prefrontal cortex share a rather rich history in neurology as brain regions involved in the inhibition of autonomic and emotional responses to fear-inducing stimuli (Cannon, 1929; Papez, 1937; MacLean, 1949; see LeDoux, 1987 , for a review). Thus, considering the high level of integration of defensive responses to stress, it is not surprising that these regions should emerge as critical sites in the regulation of endocrine responses to stress.
